Different additional risk factors for cerebral infarctions associated with the factor V Leiden mutation in a family

Journal of Child Neurology

Volumn 21, Issue 10, 2006, Pages 903-907

  Vagiakou, Eleni A ^a   Voudris, Konstantinos A ^b   Dimitriou, Yvonne ^c   Skardoutsou, Angeliki ^d   Mastroyianni, Sotiria ^b  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^c NIMITS Hospital   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETA2 GLYCOPROTEIN 1 ANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; CEFOTAXIME; LIPOPROTEIN; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN;

ACUTE GASTROENTERITIS; ANTIBODY TITER; ARTICLE; BEHAVIOR DISORDER; BRAIN ATROPHY; BRAIN INFARCTION; CASE REPORT; CEREBRAL PALSY; COGNITIVE DEFECT; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES CULTURE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GASTROENTERITIS; GENE MUTATION; GENOME ANALYSIS; HEMIPARESIS; HETEROZYGOSITY; HUMAN; INFANT; LIPOPROTEIN BLOOD LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL MORBIDITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; PUTAMEN; QUADRIPLEGIA; RESPIRATORY TRACT DISEASE; RISK FACTOR; SHIGELLA FLEXNERI; SHIGELLOSIS; SPEECH DISORDER; THROMBOGENICITY;

ADULT; ANTIBODIES; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; CEREBRAL INFARCTION; FACTOR V; FAMILY HEALTH; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); MUTATION; RESPIRATION DISORDERS; RISK FACTORS;

EID: 33846238559     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738060210100601     Document Type: Article

References (41)

1. Nowak-Gottl U, Strater R, Dubbers A, et al: Ischaemic stroke in infancy and childhood: Role of the Arg506 to Gln mutation in the factor V gene. Blood Coagul Fibrinolysis, 1996;7:684-687.
2. Thorarensen O, Ryan S, Hunter J, Yomkin DP: Factor V Leiden mutation: An unrecognised cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neural 1997;42:372-375.
3. Nelson KB, Dambrosia JM, Grether JK, Phillips TM: Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neural 1998;44:665-675.
4. Debus O, Koch HG, Kurlemann G, et al: Factor V Leiden and genetic defects of thrombophilia in childhood porencephaly. Arch Dis Child Fetal Neonatal Ed 1998;78:FI21-Fl24.
5. Harum KH, Hoon AH Jr, Casella JF: Factor-V Leiden: A risk factor for cerebral palsy. Dev Med Child Neural 1999;41:781-785.
6. Heller C, Becker S, Scharrer I, Kreuz W: Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr 1999; 158(Suppl 3):S117-S121.
7. Gaustadnes M, Rudiger N, Moller J, et al: Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. Blood Coagul Fibrinolysis 1999;10:251-259.
8. Nowak-Gottl U, Strater R, Heinecke A, et al: Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94:3678-3682.
9. Kenet G, Sadetzki S, Murad H, et al: Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283-1288.
10. Gunther G, Junker R, Strater R, et al: Symptomatic ischemic stroke in full-term neonates: Role of acquired and genetic prothrombotic risk factors. Stroke 2000;31:2437-2441.
11. Lynch JK, Nelson KB, Curry CJ, Grether JK Cerebrovascular disorders in children with the factor V Leiden mutation. J Child Neurol 2001;16:735-744.
12. Akar N, Akar E, Yilmaz E, Deda G: Plasminogen activator inhibitor-1 4G/ 5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation. J Child Neural 2001;16:294-295.
13. Barreirinho S, Ferro A, Santos M, et al: Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neural 2003;28:134-138.
14. Mercuri E, Cowan F, Gupte G, et al: Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics 2001;107:1400-1404.
15. Lynch JK, Hirtz DG, De Veber G, Nelson KB: Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 2002;109:116-123.
16. Nestoridi E, Buonanno FS, Jones RM, et al: Arterial ischemic stroke in childhood: The role of plasma-phase risk factors. Curr Opin Neural 2002;15:139-144.
17. Voudris K, Skardoutsou A, Vagiakou E: Congenital microcephaly in two infants with the factor V Leiden mutation. J Child Neurol 2002; 17: 905-907.
18. Duran R, Biner B, Demir M, et al: Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin Appl Thromb Hemost 2005;11:83-88.
19. De Veber G, Monagle P, Chan A, et al: Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998;55:1539-1543.
20. Green D: Thrombophilia and stroke. Top Stroke Rehabil 2003;10:21-33.
21. Schoning M, Klein R, Krageloh-Mann I, et al: Antiphospholipid antibodies in cerebrovascular ischemia, and stroke in childhood. Neuropediatrics 1994;25:8-14.
22. Angelini L, Ravelli A, Caporali R, et al: High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994;94:500-503.
23. Baca V, Garcia-Ramirez R, Ramirez-Lacayo M, et al: Cerebral infarction and antiphospholipid syndrome in children. J Rheumatol 1996;23:1428-1431.
24. Golomb MR, Mac Gregor DL, Domi T, et al: Presumed pre- or perinatal arterial ischemic stroke: Risk factors and outcomes. Ann Neurol 2001;50:163-168.
25. Cardo E, Monros E, Colome C, et al: Children with stroke: Polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neural 2000;15:295-298.
26. Prengler M, Sturt N, Krywawych S, et al: Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: A potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood. Dev Med Child Neural 2001;43:220-225.
27. Haywood S, Liesner R, Pindora S, Ganesan V: Thrombophilia, and first arterial ischaemic stroke: A systemic review. Arch Dis Child 2005;90: 402-405.
28. Alluri RV, Mohan V, Komandur S, et al: MTHFR C677T gene mutation as a risk factor for arterial stroke: A hospital based study. Eur J Neurol 2005;12:40-44.
29. van Beynum IM, Smeitink JA, den Heijer M, et al: Hyperhomocysteinemia: A risk factor for ischemic stroke in children. Circulation 1999;99:2070-2072.
30. Hogeveen M, Blom HJ, Van Amerongen M, et al: Hyperhomocysteinemia as risk factor for ishemic and hemorrhagic stroke in newborn infants. J Pediatr 2002;141:429-431.
31. Kelly PJ, Rosand J, Kistler JP, et al: Homocystein, MTHFR 677C T polymorphism, and risk of ischemic stroke. Results of a meta-analysis. Neurology 2002;59:529-536.
32. Dizon-Townson DS, Melin L, Nelson LM, et al: Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-405.
33. Nelson KB, Grether JK: Causes of cerebral palsy. Curr Opin Pediatr 1999;11:487-491.
34. Pablos JL, Caliz RA, Carreira PE, et al: Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation. J Rheumatol 1999;26:588-590.
35. Avcin T, Cimaz R, Meroni PL: Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002;11:4-10.
36. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 2002;346:752-763.
37. Von Scheven E, Glidden DV, Elder ME: Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2002;47:414-420.
38. Voss A, Jacobsen S, Heegaard NHH: Association of β2-glycoprotein I IgG and IgM antibodies with thrombosis and thombocytopenia. Lupus 2001;10:533-538.
39. Roddy SM, Giang DW: Antiphospholipid antibodies and stroke in an infant. Pediatrics 1991;87:933-935.
40. Chow G, Mellor D: Neonatal cerebral ishaemia with elevated matemal and infant anticardiolipin antibodies. Dev Med Child Neural 2000;42:412-413.
41. Kurnik K, Kosch A, Strater R, et al: Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: A prospective follow-up study. Stroke 2003;34:2887-2892.